Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk

Regardless of the promising results of certain immune checkpoint blockers, current immunotherapeutics have met a bottleneck concerning response rate, toxicity, and resistance in lung cancer patients. Accumulating evidence forecasts that the crosstalk between tumor and immune cells takes center stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarode, Poonam, Schaefer, Martina Barbara, Grimminger, Friedrich, Seeger, Werner, Savai, Rajkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078651/
https://www.ncbi.nlm.nih.gov/pubmed/32219066
http://dx.doi.org/10.3389/fonc.2020.00324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078651/
https://www.ncbi.nlm.nih.gov/pubmed/32219066
http://dx.doi.org/10.3389/fonc.2020.00324

Ejemplares similares